Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism

• COVID-19 pneumonia could be associated with an increased risk of venous thrombosis. • Antiphospholipid antibodies might be involved in thrombosis in COVID-19 patients. • Prevalence of antiphospholipid antibodies in COVID-19 and venous thrombosis was low.

Detalles Bibliográficos
Autores principales: Galeano-Valle, F., Oblitas, C.M., Ferreiro-Mazón, M.M., Alonso-Muñoz, J., del Toro-Cervera, J., di Natale, M., Demelo-Rodríguez, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227496/
https://www.ncbi.nlm.nih.gov/pubmed/32425261
http://dx.doi.org/10.1016/j.thromres.2020.05.017
_version_ 1783534507872223232
author Galeano-Valle, F.
Oblitas, C.M.
Ferreiro-Mazón, M.M.
Alonso-Muñoz, J.
del Toro-Cervera, J.
di Natale, M.
Demelo-Rodríguez, P.
author_facet Galeano-Valle, F.
Oblitas, C.M.
Ferreiro-Mazón, M.M.
Alonso-Muñoz, J.
del Toro-Cervera, J.
di Natale, M.
Demelo-Rodríguez, P.
author_sort Galeano-Valle, F.
collection PubMed
description • COVID-19 pneumonia could be associated with an increased risk of venous thrombosis. • Antiphospholipid antibodies might be involved in thrombosis in COVID-19 patients. • Prevalence of antiphospholipid antibodies in COVID-19 and venous thrombosis was low.
format Online
Article
Text
id pubmed-7227496
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72274962020-05-18 Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism Galeano-Valle, F. Oblitas, C.M. Ferreiro-Mazón, M.M. Alonso-Muñoz, J. del Toro-Cervera, J. di Natale, M. Demelo-Rodríguez, P. Thromb Res Article • COVID-19 pneumonia could be associated with an increased risk of venous thrombosis. • Antiphospholipid antibodies might be involved in thrombosis in COVID-19 patients. • Prevalence of antiphospholipid antibodies in COVID-19 and venous thrombosis was low. Elsevier Ltd. 2020-08 2020-05-15 /pmc/articles/PMC7227496/ /pubmed/32425261 http://dx.doi.org/10.1016/j.thromres.2020.05.017 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Galeano-Valle, F.
Oblitas, C.M.
Ferreiro-Mazón, M.M.
Alonso-Muñoz, J.
del Toro-Cervera, J.
di Natale, M.
Demelo-Rodríguez, P.
Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism
title Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism
title_full Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism
title_fullStr Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism
title_full_unstemmed Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism
title_short Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism
title_sort antiphospholipid antibodies are not elevated in patients with severe covid-19 pneumonia and venous thromboembolism
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227496/
https://www.ncbi.nlm.nih.gov/pubmed/32425261
http://dx.doi.org/10.1016/j.thromres.2020.05.017
work_keys_str_mv AT galeanovallef antiphospholipidantibodiesarenotelevatedinpatientswithseverecovid19pneumoniaandvenousthromboembolism
AT oblitascm antiphospholipidantibodiesarenotelevatedinpatientswithseverecovid19pneumoniaandvenousthromboembolism
AT ferreiromazonmm antiphospholipidantibodiesarenotelevatedinpatientswithseverecovid19pneumoniaandvenousthromboembolism
AT alonsomunozj antiphospholipidantibodiesarenotelevatedinpatientswithseverecovid19pneumoniaandvenousthromboembolism
AT deltorocerveraj antiphospholipidantibodiesarenotelevatedinpatientswithseverecovid19pneumoniaandvenousthromboembolism
AT dinatalem antiphospholipidantibodiesarenotelevatedinpatientswithseverecovid19pneumoniaandvenousthromboembolism
AT demelorodriguezp antiphospholipidantibodiesarenotelevatedinpatientswithseverecovid19pneumoniaandvenousthromboembolism

Ejemplares similares